You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4076 to 4100 of about 5901
Next 25
01/26/2007
Advances in the Management of Glioblastoma Multiforme: An Expert Interview With Dr. Renato La Rocca From 2006 SNO
01/24/2007
SAMUEL J FOUNDATION FUNDRAISER TO SUPPORT KIDS WITH BRAIN TUMORS
OSI drug tested on tumors in kids
01/23/2007
Publication of Early Research on Callisto Pharmaceutical`s Degrasyn Drug Class Suggests Potential to Treat Brain Tumors
01/20/2007
You can now donate your american express points!
01/19/2007
Statin plus cancer drug deliver combo punch to brain cancer cells
01/17/2007
Experiment at Stony Brook delivers drugs into arteries that feed the brain, targeting aggressive tumors
Long-used drug shows new promise for cancer
Updated survivor story Peter D. - a 12+ year GBM survivor!
Updated survivor story Scott - a 5+ year Oligo survivor!
Updated survivor story - Donna - a 6+ year GBM survivor!
Updated survivor story - Alex - 4.5 year survivor pediatric gbm!
Drug Shows Promise for Preventing Brain Injury from Radiation
01/16/2007
Our website was named Resource of the Month by the Tug McGraw foundation
Small Blood Vessels Linked to Brain Tumors
Creating a new kind of cancer treatment
01/13/2007
Brain tumour treatment is a world first
New Anti-angiogenesis Treatment: Combination Therapy Obliterates New Vessel Growth In Tumors And Retinopathy
01/08/2007
Updated a survivor story!
Neuralstem (OTC Bulletin Board: NRLS) Receives Notice of Intention to Grant Core Patent From European Patent Office
01/07/2007
Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
Temozolomide in advanced malignant melanoma with small brain metastases: can we Withhold Cranial Irradiation?
Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy.
Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).